It was quick, and afterward, I donned a Band-Aid with the Truvian logo. In the next room ... some high-profile figures in laboratory and diagnostics. Dr. Tina Nova, former president and CEO ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...

The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers ...

If you ever had cancer or were tested for it, there’s a good chance Roche Tissue Diagnostics played a role behind the scenes. The Tucson-area company has emerged as a global leader in ...

This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...

Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...

FRANKFURT, Jan 30 (Reuters) - Roche (ROG.S), opens new tab said on ... would mark continued earnings momentum as the Swiss drugs and diagnostics company said in its earnings statement that ...

After a general alignment of the company’s structures, Roche was left with four core business sectors – pharmaceuticals, vitamins and fine chemicals, diagnostics, and flavours and fragrances.

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above ...